Protecting Americans from Drug Marketing Act
Official title: A bill to amend the Internal Revenue Code of 1986 to deny the deduction for advertising and promotional expenses for prescription drugs.
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Read twice and referred to the Committee on Finance.
Protecting Americans from Drug Marketing Act
This bill amends the Internal Revenue Code to deny a tax deduction for the cost of direct-to-consumer advertising of prescription drugs. The bill defines "direct-to-consumer advertising" as any dissemination by or on behalf of a sponsor of a prescription drug product of a prescription drug advertisement that is primarily targeted to the general public through: (1) publication in journals, magazines, other periodicals, and newspapers; (2) broadcasting through media such as radio, television, and telephone communication systems; and (3) dissemination on the Internet (including social media).
- Introduced in Senate Formatted Text PDF Formatted XML
Cite this page
U.S. Congress. (2026). S. 2623: Protecting Americans from Drug Marketing Act. 114th Congress. Open America. https://openamerica.io/bill/114-S-2623/
"S. 2623: Protecting Americans from Drug Marketing Act." 114th Congress, 2026, Open America, https://openamerica.io/bill/114-S-2623/.
S. 2623, 114th Cong. (2026), https://openamerica.io/bill/114-S-2623/.
[S. 2623: Protecting Americans from Drug Marketing Act](https://openamerica.io/bill/114-S-2623/)